Skip to main content

CORRECTION article

Front. Endocrinol., 03 December 2024
Sec. Obesity
Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1528628

Corrigendum: Editorial: Mechanistic insight and therapeutic potential for the management of non-alcoholic steatohepatitis (NASH)

This article is a correction to:

  1. Editorial: Mechanistic insight and therapeutic potential for the management of non-alcoholic steatohepatitis (NASH)

    1. Read original article
Umashanker Navik*Umashanker Navik1*Amit KhuranaAmit Khurana1Jasvinder Singh Bhatti*Jasvinder Singh Bhatti2*
  • 1Department of Pharmacology, Central University of Punjab, Bathinda Punjab, India
  • 2Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India

A Corrigendum on
Editorial: Mechanistic insight and therapeutic potential for the management of non-alcoholic steatohepatitis (NASH)

By Navik U, Khurana A and Singh Bhatti J (2024). Front. Endocrinol. 15:1503460. doi: 10.3389/fendo.2024.1503460

In the published article, there was an error in the affiliation and correspondence author. Instead of

“Umashanker Navik*, Amit Khurana and Jasvinder Singh Bhatti

Department of Pharmacology, Central University Punjab, Bathinda Punjab, India

*CORRESPONDENCE

Umashanker Navik, usnavik@gmail.com”, it should be

“Umashanker Navik1*, Amit Khurana1 and Jasvinder Singh Bhatti2*

1Department of Pharmacology, Central University of Punjab, Bathinda Punjab, India

2Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India.

*CORRESPONDENCE

Umashanker Navik, usnavik@gmail.com

Jasvinder Singh Bhatti, jasvinder.bhatti@cup.edu.in”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: non-alcoholic steatohepatitis (NASH), genistein, yes-associated Protein (YAP), liver enzyme markers, glucose-to-albumin ratio

Citation: Navik U, Khurana A and Bhatti JS (2024) Corrigendum: Editorial: Mechanistic insight and therapeutic potential for the management of non-alcoholic steatohepatitis (NASH). Front. Endocrinol. 15:1528628. doi: 10.3389/fendo.2024.1528628

Received: 15 November 2024; Accepted: 18 November 2024;
Published: 03 December 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Navik, Khurana and Bhatti. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Umashanker Navik, dXNuYXZpa0BnbWFpbC5jb20=; Jasvinder Singh Bhatti, amFzdmluZGVyLmJoYXR0aUBjdXAuZWR1Lmlu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.